Suvexx, a combination migraine treatment imported and supplied by SK Chemicals, will be reimbursed in Korea next month.

Suvexx is a combination of sumatriptan, a triptan-class drug most commonly used for migraine, and naproxen, a non-steroidal anti-inflammatory drug (NSAID).

According to industry sources on the 26th, Suvexx will be listed for reimbursement at KRW 5,042 per tablet starting on the first of next month.

There has never been a combination drug combining sumatriptan naproxen in Korea. Furthermore, the individual ingredients, sumatriptan succinate 85mg and naproxen sodium 500mg, are not registered on the reimbursement list.

Therefore, HIRA applied